-transparent.png){kind=logo}
In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule. The patient was maintained on amiodarone and developed thyrotoxicosis as a result of a destructive process into the thyroid follicles. Amiodarone was withdrawn and methylprednisolone and methimazole treatment was started with resolution of the thyrotoxic phase. Months later, off therapy, the patient developed subclinical hypothyroidism. This is the first description of hypo- and hyperthyroidism in the same patient caused by amiodarone therapy. This unusual observation suggests that patients treated with amiodarone are at risk to develop hyperthyroidism even if they show laboratory findings consistent with hypothyroidism.
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
January 1983,
Giornale italiano di cardiologia,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
March 1992,
Recenti progressi in medicina,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
May 2022,
Journal of midwifery & women's health,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
September 2000,
Revista clinica espanola,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
April 1990,
Revista espanola de cardiologia,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
December 2005,
Georgian medical news,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
August 2006,
Obstetrical & gynecological survey,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
June 1991,
The American journal of medicine,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
October 1999,
The American journal of the medical sciences,
R Minelli, and
E Gardini, and
L Bianconi, and
M Salvi, and
E Roti
January 2002,
Thyroid : official journal of the American Thyroid Association,
